|
Fortis-M Data:
Press Release
Conference Call Webcast link
Factsheets:
Corporate overview
About oral talactoferrin alfa
Management Board and Executive Committee
For more information on oral talactoferrin alfa, please klick here
Pictures:
Management Board
Torsten Hombeck, Ph.D.
Chief Financial Officer
and Spokesperson of the Management Board
JPG, 133KB
Rajesh Malik, M.D.
Chief Medical Officer
JPG, 295KB
back to top
Talactoferrin alfa
Investigational agent
Oral Dendritic Cell Mediated Immunotherapie (DCMI)
One bottle of talactoferrin alfa, oral solution (labeled)
JPG-download, 104KB
One bottle of talactoferrin alfa, oral solution (no label)
JPG-download, 406KB
Set of three bottles of talactoferrin alfa, oral solution (labeled)
JPG-download, 556KB
back to top
Logos:
For Web:
PNG-download, 8KB
JPG-download, 44KB
For Print:
JPG-download, 743KB
back to top
If you have any questions or need more information, please contact:
In Germany:
Barbara Mueller
Manager, Investor Relations
& Corporate Communications
Phone: +49 (0)89 8565 2693
Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
In the U.S.:
Laurie Doyle
Senior Director, Investor Relations
& Corporate Communications
Phone: +1 609 524 5884
Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
Additional media contact for Europe:
MC Services AG
Raimund Gabriel
Phone: +49 (0) 89 210 228 0
Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
|
